Last reviewed · How we verify

NCT04116216

rTMS on Motor Function of Parkinson's Disease Patients With Different Phenotypes

Status unknown Phase 2 Last updated 4 October 2019
What this trial tests

Phase 2 trial testing High frequency repetitive transcranial magnetic stimulation in Parkinson Disease in 30 participants. Status unknown.

Timeline
15 October 2019
Primary endpoint
30 December 2020
30 April 2021

Quick facts

Lead sponsorUniversidade Federal de Pernambuco
PhasePhase 2
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment30
Start date15 October 2019
Primary completion30 December 2020
Estimated completion30 April 2021
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Universidade Federal de Pernambuco — full company profile →

Who can join

40 and older, any sex, with Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study we wondered whether patients with different phenotypes of Parkinson's disease respond differently to the protocol of repetitive transcranial magnetic stimulation (rTMS) associated with physical therapy. Furthermore, the study aims to compare the effects of rTMS protocols (high and low frequency) associated with physical therapy in PD patients with different phenotypes regarding to motor performance; bradykinesia; functional mobility; balance; quality of life; perception of improvement.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Novel targeted therapies for Parkinson's disease.
    Ntetsika T, Papathoma PE, Markaki I. · · 2021 · cited 78× · PMID 33632120 · DOI 10.1186/s10020-021-00279-2

Verify or expand the search:

Other trials of High frequency repetitive transcranial magnetic stimulation

Trials testing the same drug.

Other recruiting trials for Parkinson Disease

Currently open trials in the same condition.

Other Universidade Federal de Pernambuco trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04116216.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing